Commonwealth Equity Services Portfolio holdings
AUM
$75.7B
1-Year Return
17%
This Quarter Return
+1.69%
1 Year Return
+17%
3 Year Return
+64.32%
5 Year Return
+107.58%
10 Year Return
+207.41%
AUM
$68.4B
AUM Growth
+$2.43B
(+3.7%)
Cap. Flow
+$2.13B
Cap. Flow
% of AUM
3.12%
Top 10 Holdings %
Top 10 Hldgs %
19.98%
Holding
4,281
New
226
Increased
2,094
Reduced
1,680
Closed
194
Top Buys
| 1 |
Vanguard S&P 500 ETF
VOO
|
$51M |
| 2 |
Fidelity Enhanced Large Cap Core ETF
FELC
|
$43M |
| 3 |
Microsoft
MSFT
|
$41.5M |
| 4 |
iShares Core Dividend Growth ETF
DGRO
|
$41.3M |
| 5 |
FT Vest Fund of Buffer ETFs
BUFR
|
$36.1M |
Top Sells
| 1 |
IBDP
iShares iBonds Dec 2024 Term Corporate ETF
IBDP
|
$31.5M |
| 2 |
iShares ESG Aware MSCI USA ETF
ESGU
|
$29.4M |
| 3 |
Vanguard Long-Term Bond ETF
BLV
|
$22.7M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
$21.4M |
| 5 |
Invesco Russell 1000 Dynamic Multifactor ETF
OMFL
|
$18.1M |
Sector Composition
| 1 | Technology | 12.95% |
| 2 | Financials | 5.41% |
| 3 | Consumer Discretionary | 4.35% |
| 4 | Healthcare | 3.33% |
| 5 | Industrials | 3.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
4001
Creative Realities
CREX
$24.5M
| $37K | ﹤0.01% |
+15,100
| New | +$37K |
|
4002
Aclaris Therapeutics
ACRS
$225M
| $36K | ﹤0.01% |
+14,694
| New | +$36K |
|
|
BITF
4003
Bitfarms
BITF
$702M
| $36K | ﹤0.01% |
24,105
+2,319
| +11% | +$3.46K |
|
4004
Denison Mines
DNN
$2.06B
| $36K | ﹤0.01% |
19,964
+8,500
| +74% | +$15.3K |
|
4005
NovaGold Resources
NG
$2.74B
| $34K | ﹤0.01% |
10,115
-23,396
| -70% | -$78.6K |
|
4006
3D Systems Corporation
DDD
$267M
| $33K | ﹤0.01% |
10,199
-636
| -6% | -$2.06K |
|
|
WIMI
4007
WiMi Hologram Cloud
WIMI
$37.8M
| $33K | ﹤0.01% |
+1,800
| New | +$33K |
|
4008
AdvisorShares Pure Cannabis ETF
YOLO
$41.8M
| $33K | ﹤0.01% |
13,517
-1,059
| -7% | -$2.59K |
|
4009
Compugen
CGEN
$134M
| $32K | ﹤0.01% |
+20,791
| New | +$32K |
|
4010
Esperion Therapeutics
ESPR
$534M
| $32K | ﹤0.01% |
14,737
-4,500
| -23% | -$9.77K |
|
4011
reAlpha
AIRE
$33.5M
| $31K | ﹤0.01% |
10,800
| – | – |
|
4012
Gossamer Bio
GOSS
$653M
| $31K | ﹤0.01% |
34,471
| – | – |
|
4013
Assertio
ASRT
$76.8M
| $30K | ﹤0.01% |
+34,101
| New | +$30K |
|
4014
Lineage Cell Therapeutics
LCTX
$279M
| $30K | ﹤0.01% |
58,708
+10,447
| +22% | +$5.34K |
|
|
UROY
4015
Uranium Royalty Corp
UROY
$432M
| $30K | ﹤0.01% |
13,761
+612
| +5% | +$1.33K |
|
4016
ALX Oncology
ALXO
$64.3M
| $28K | ﹤0.01% |
16,909
+1,069
| +7% | +$1.77K |
|
|
CNTB
4017
Connect Biopharma Holdings Limited Ordinary Shares
CNTB
$96.4M
| $28K | ﹤0.01% |
20,000
| – | – |
|
|
EMX
4018
EMX Royalty
EMX
$443M
| $28K | ﹤0.01% |
16,019
| – | – |
|
|
FLNT
4019
Fluent
FLNT
$54.1M
| $28K | ﹤0.01% |
11,112
-1,600
| -13% | -$4.03K |
|
4020
Solidion Technology
STI
$17.6M
| $28K | ﹤0.01% |
+800
| New | +$28K |
|
4021
Gores Guggenheim
PSNY
$2.14B
| $27K | ﹤0.01% |
25,672
-2,000
| -7% | -$2.1K |
|
|
AFMD
4022
DELISTED
Affimed
AFMD
| $25K | ﹤0.01% |
21,374
-379
| -2% | -$443 |
|
|
LUNA
4023
DELISTED
Luna Innovations Incorporated
LUNA
| $25K | ﹤0.01% |
11,351
-5,241
| -32% | -$11.5K |
|
4024
Editas Medicine
EDIT
$239M
| $24K | ﹤0.01% |
18,828
-815
| -4% | -$1.04K |
|
4025
Genelux
GNLX
$129M
| $24K | ﹤0.01% |
10,083
-3,484
| -26% | -$8.29K |
|